{
    "2019-08-12": [
        [
            {
                "time": "2019-06-14",
                "original_text": "UPDATE 1-Senator Grassley seeks info on Novartis's Zolgensma data issues",
                "features": {
                    "keywords": [
                        "Senator Grassley",
                        "Novartis",
                        "Zolgensma",
                        "data issues"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-06-14",
                "original_text": "Senator Grassley seeks info on Novartis's Zolgensma data issues",
                "features": {
                    "keywords": [
                        "Senator Grassley",
                        "Novartis",
                        "Zolgensma",
                        "data issues"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-06-15",
                "original_text": "The Biggest Biotech Stock Is Approaching A Breakout — Here's Why",
                "features": {
                    "keywords": [
                        "biotech",
                        "breakout"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-15",
                "original_text": "Amgen wins U.S. patent battle on arthritis drug Enbrel",
                "features": {
                    "keywords": [
                        "Amgen",
                        "patent",
                        "Enbrel",
                        "arthritis"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-15",
                "original_text": "Amgen stock gets boost from Friday ruling on Enbrel",
                "features": {
                    "keywords": [
                        "Amgen",
                        "stock",
                        "boost",
                        "Enbrel"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-15",
                "original_text": "Amgen Wins Enbrel U.S. Patent Litigation Against Novartis",
                "features": {
                    "keywords": [
                        "Amgen",
                        "Enbrel",
                        "patent",
                        "litigation",
                        "Novartis"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-15",
                "original_text": "Amgen’s Court Win Could Mark ‘a New Dawn’ for the Stock",
                "features": {
                    "keywords": [
                        "Amgen",
                        "court win",
                        "new dawn"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-15",
                "original_text": "[video]Amgen Climbs After Winning Patent Case on Enbrel",
                "features": {
                    "keywords": [
                        "Amgen",
                        "climbs",
                        "patent case",
                        "Enbrel"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-15",
                "original_text": "Amgen Climbs After Winning Patent Case on Enbrel",
                "features": {
                    "keywords": [
                        "Amgen",
                        "climbs",
                        "patent case",
                        "Enbrel"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-15",
                "original_text": "5 Big Pharma Showdowns to Watch",
                "features": {
                    "keywords": [
                        "Big Pharma",
                        "showdowns"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}